Mesenchymal modulation of epithelial metaplasia in lung fibrosis
Description: Project Narrative Efforts to treat Idiopathic pulmonary fibrosis (IPF), the most common and deadly form of a large group of lung fibrotic diseases, have mostly targeted the scarring process. However, IPF is also characterized by the appearance of abnormal stem cell populations in areas of damage, a process known as metaplasia. The studies outlined in this proposal will test the idea that metaplasia can alter lung function in fibrotic diseases, and develop a pre-clinical pipeline to test therapies that can target metaplasia in patients with IPF.
Funding type: research
Funder scheme: R01
Start date: 2021-02-01
End date: 2024-12-31
Investigator: TIEN PENG (lead)
Institution: University of California, San Francisco
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Funded outputs count: 9
Funder award ID: R01HL155622
OpenAlex ID: G4570856137
